Sign in
Knowstox

Fundamentals snapshot

COMPASS Pathways plc

CMPS · NMS · Healthcare · Medical Care Facilities

Current price

$12.28

52-week range

$4.88 - $15.87

Market cap

$1.70B

One-glance verdict

Not enough data

Fair value unavailable

Not enough cash-flow history to value this one with our method.

Balance sheet

Healthy

-38.81x Concerning

Net cash $378.67M. Interest coverage shows how many times profit covers the interest bill.

What this company does

COMPASS Pathways plc

COMPASS Pathways plc is a company developing a new therapy for mental health conditions using a compound found in psychedelic mushrooms, mainly for severe depression, and is also testing it for PTSD and eating disorders. Their main money will eventually come from selling this therapy to healthcare providers once it's approved by regulators, which matters because it's a new approach to treating difficult mental health problems.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-22.18M FY2024 Q4 $-41.76M
Revenue —
Net income $-253.79M
Diluted EPS -1.88
Operating cash flow $-40.31M
Free cash flow —
Revenue —
Net income $91.20M
Diluted EPS -0.30
Operating cash flow $-47.94M
Free cash flow —
Revenue —
Net income $-93.88M
Diluted EPS -0.99
Operating cash flow $-37.79M
Free cash flow —
Revenue —
Net income $-137.72M
Diluted EPS -1.44
Operating cash flow $-35.11M
Free cash flow —
Revenue —
Net income $-38.40M
Diluted EPS -0.41
Operating cash flow $-38.69M
Free cash flow —
Revenue —
Net income $-17.86M
Diluted EPS -0.24
Operating cash flow $-45.66M
Free cash flow —
Revenue —
Net income $-43.33M
Diluted EPS 558.81
Operating cash flow $-41.76M
Free cash flow $-41.76M
Revenue —
Net income $-38.50M
Diluted EPS -0.56
Operating cash flow $-22.18M
Free cash flow $-22.18M

Is it cheap or expensive?

Fair value — vs current price $12.28

We couldn't calculate a fair value right now.

lower confidence

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Is it drowning in debt?

Healthy

Net cash $378.7M - more cash than debt. Interest coverage -38.8x.

Net debt $-378.67M
Interest coverage -38.81x

COMPASS Pathways plc's profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 1 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Healthy
Worse cushion Baseline Better cushion
CMPS BASELINE COMPASS Pathways plc

Total debt $54.63M Interest coverage -38.81x This is the baseline the peer rows are being compared against.

-38.81x
ATAI AtaiBeckley Inc.

Total debt $4.29M Interest coverage -97.54x Neither company has much profit cushion over interest right now.

-97.54x

What you should know

The case for and against CMPS

0 Rewards 1 Risk

Rewards

Risks

  • Return on equity was -319.1% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
-8.57x
P/B
19.71x
P/S
—
EV/EBITDA
-6.77x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
ROE
-319.1%
ROA
-29.1%

Health

Liquidity and balance-sheet strength

Debt / equity
0.65x
Current ratio
1.29x
Quick ratio
1.22x
Total debt
$54.63M
Total cash
$433.30M

Growth

How the business has been compounding

Revenue TTM
$0.00
Revenue 5Y CAGR
—
EPS TTM
-3.76
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$-161.14M
Free CF TTM
$-119.19M
FCF margin
—

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
—
Last ex-div date
—